Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. https://doi.org/10.3322/caac.21834.
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics. Cancer JC. 2024;74(1):12–49. https://doi.org/10.3322/caac.21820. Epub 2024 Jan 17. Erratum in: CA Cancer J Clin. 2024 Mar-Apr;74(2):203. PMID: 38230766.
Siegel RL, Wagle NS, Cercek A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233–54. https://doi.org/10.3322/caac.21772.
Eng C, Jácome AA, Agarwal R, et al. A comprehensive framework for early-onset colorectal cancer research. Lancet Oncol. 2022;23(3):e116–28. https://doi.org/10.1016/S1470-2045(21)00588-X.
Zaborowski AM, Abdile A, Adamina M, REACCT Collaborative, et al. Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review. JAMA Surg. 2021;156(9):865–74. https://doi.org/10.1001/jamasurg.2021.2380. Erratum in: JAMA Surg. 2021 Sep 1;156(9):894. doi: 10.1001/jamasurg.2021.4077. PMID: 34190968.
Mahul BA, Stephen E, Frederick LG, et al. AJCC cancer staging manual [M]. 8th ed. New York: Springer; 2016.
Benson AB, Venook AP, Al-Hawary MM, et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(3):329–59. https://doi.org/10.6004/jnccn.2021.0012.
Benson AB, Venook AP, Al-Hawary MM, et al. Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(10):1139–67. https://doi.org/10.6004/jnccn.2022.0051.
Article CAS PubMed Google Scholar
Farah E, Abreu AA, Rail B, et al. Perioperative outcomes of robotic and laparoscopic surgery for colorectal cancer: a propensity score-matched analysis. World J Surg Oncol. 2023;21(1):272. https://doi.org/10.1186/s12957-023-03138-y.
Article PubMed PubMed Central Google Scholar
Lieu CH, Golemis EA, Serebriiskii IG, et al. Comprehensive genomic landscapes in early and later onset colorectal cancer. Clin Cancer Res. 2019;25(19):5852–8. https://doi.org/10.1158/1078-0432.CCR-19-0899.
Article CAS PubMed PubMed Central Google Scholar
Cai Z, Song H, Fingerhut A, Sun J, Ma J, Zhang L, et al. A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer. BMC Cancer. 2021;21(1):319. https://doi.org/10.1186/s12885-021-08044-8.
Article CAS PubMed PubMed Central Google Scholar
Fujii S, Magliocco AM, Kim J, Okamoto W, Kim JE, Sawada K, Nakamura Y, Kopetz S, Park WY, Tsuchihara K, Kim TW, Raghav K, Yoshino T. International Harmonization of Provisional Diagnostic Criteria for ERBB2-Amplified Metastatic Colorectal Cancer Allowing for Screening by Next-Generation Sequencing Panel. JCO Precis Oncol. 2020;4:6–19. https://doi.org/10.1200/PO.19.00154.
Foppa C, Tamburello S, Maroli A, et al. Early age of onset is an independent predictor for worse disease-free survival in sporadic rectal cancer patients. A comparative analysis of 980 consecutive patients. Eur J Surg Oncol. 2022;48(4):857–63. Epub 2021 Oct 28. PMID: 34740480.
Liang Z, Xiang D, Feng J, et al. Log odds of positive lymph nodes show better predictive performance on the prognosis of early-onset colorectal cancer. Int J Colorectal Dis. 2023;38(1):192. https://doi.org/10.1007/s00384-023-04490-x.
O’Sullivan DE, Sutherland RL, Town S, et al. Risk factors for Early-Onset colorectal cancer: A systematic review and Meta-analysis. Clin Gastroenterol Hepatol. 2022;20(6):1229–e12405. https://doi.org/10.1016/j.cgh.2021.01.037. Epub 2021 Jan 29. PMID: 33524598.
Pan Z, Huang J, Huang M, et al. Risk factors for early-onset colorectal cancer: a large-scale Chinese cohort study. J Natl Cancer Cent. 2023;3(1):28–34. https://doi.org/10.1016/j.jncc.2023.01.001.
Article PubMed PubMed Central Google Scholar
Cercek A, Chatila WK, Yaeger R, et al. A comprehensive comparison of early-onset and average-onset colorectal cancers. J Natl Cancer Inst. 2021;113(12):1683–92. https://doi.org/10.1093/jnci/djab124.
Article CAS PubMed PubMed Central Google Scholar
Chen FW, Sundaram V, Chew TA, et al. Advanced-Stage colorectal cancer in persons younger than 50 years not associated with longer duration of symptoms or time to diagnosis. Clin Gastroenterol Hepatol. 2017;15(5):728–e7373. https://doi.org/10.1016/j.cgh.2016.10.038. Epub 2016 Nov 14. PMID: 27856366; PMCID: PMC5401776.
Lawler T, Parlato L, Warren Andersen S. The histological and molecular characteristics of early-onset colorectal cancer: a systematic review and meta-analysis. Front Oncol. 2024;14:1349572. https://doi.org/10.3389/fonc.2024.1349572.
Article CAS PubMed PubMed Central Google Scholar
Ionescu VA, Gheorghe G, Baban IA, et al. Prognostic differences between early-onset and late-onset colorectal cancer. Medicina (B Aires). 2025;61(3):390. https://doi.org/10.3390/medicina61030390.
Liu F, Jiang S, Cui J, Wu Y, Chen S, Yu Z. Prognostic value of the postoperative carcinoembryonic antigen level in colorectal cancer: a meta-analysis. World J Surg. 2024;48(10):2359–75. https://doi.org/10.1002/wjs.12349.
Xie H, Wei L, Wang Q, Tang S, Gan J. Grading carcinoembryonic antigen levels can enhance the effectiveness of prognostic stratification in patients with colorectal cancer: a single-centre retrospective study. BMJ Open. 2024;14(10):e084219. https://doi.org/10.1136/bmjopen-2024-084219.
Article PubMed PubMed Central Google Scholar
Lehtomäki K, Mustonen H, Kellokumpu-Lehtinen PL, et al. Lead time and prognostic role of serum CEA, CA19-9, IL-6, CRP, and YKL-40 after adjuvant chemotherapy in colorectal cancer. Cancers (Basel). 2021;13(15):3892. https://doi.org/10.3390/cancers13153892.
Article CAS PubMed Google Scholar
Polat E, Duman U, Duman M, et al. Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19 – 9 in colorectal cancer. Curr Oncol. 2014;21(1):e1–7. https://doi.org/10.3747/co.21.1711. PMID: 24523606; PMCID: PMC3921033.
Article CAS PubMed PubMed Central Google Scholar
Sun Y, Yu D, Zhong J, et al. Para-aortic lymph node dissection in left-sided colorectal cancer: risk factors, prognostic impact, and therapeutic value. J Surg Oncol. 2022;125(8):1251–9. https://doi.org/10.1002/jso.26829.
Hatate K, Yamashita K, Hirai K, et al. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9. Oncol Rep. 2008;20(4):737–43. PMID: 18813812.
Stiksma J, Grootendorst DC, van der Linden PW. CA 19 – 9 as a marker in addition to CEA to monitor colorectal cancer. Clin Colorectal Cancer. 2014;13(4):239–44. https://doi.org/10.1016/j.clcc.2014.09.004. Epub 2014 Sep 18. PMID: 25442815.
Wang R, Xu B, Sun M, et al. Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer. Eur J Surg Oncol. 2023;49(12):107138. https://doi.org/10.1016/j.ejso.2023.107138.
Emile SH, Silva-Alvarenga E, Horesh N, et al. Concordance between clinical and pathologic assessment of T and N stages of rectal adenocarcinoma patients who underwent surgery without neoadjuvant therapy: a National Cancer Database analysis. Eur J Surg Oncol. 2023;49(2):426–32. https://doi.org/10.1016/j.ejso.2022.09.014.
Pagès F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353(25):2654–66. https://doi.org/10.1056/NEJMoa051424.
Wang H, Huo R, He K, et al. Perineural invasion in colorectal cancer: mechanisms of action and clinical relevance. Cell Oncol (Dordr). 2024;47(1):1–17. https://doi.org/10.1007/s13402-023-00857-y.
Comments (0)